Cambodia Integrated HIV and Drug Prevention Implementation Program (CIPI)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by University of California, San Francisco
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01835574
First received: April 9, 2013
Last updated: July 2, 2014
Last verified: July 2014

April 9, 2013
July 2, 2014
April 2013
September 2016   (final data collection date for primary outcome measure)
HIV risk behavior [ Time Frame: 12 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01835574 on ClinicalTrials.gov Archive Site
amphetamine use [ Time Frame: 12 months ] [ Designated as safety issue: No ]
Cross-sectional behavioral risk data will be collected from approximately 1200 eligible participants at 6 timepoints (2 prior to implementation of a substance-use reduction program, two during the program, and two following the program). HIV risk behavior is to be measured by protected versus unprotected sex by partner types.
Same as current
Not Provided
Not Provided
 
Cambodia Integrated HIV and Drug Prevention Implementation Program
Cambodia Integrated HIV and Drug Prevention Implementation Program

The Cambodia Integrated HIV and Drug Prevention Implementation Program project will implement and evaluate an integrated combination HIV prevention intervention: SMARTgirl Plus for Cambodian female entertainment and sex workers where non-injection use of amphetamine type stimulant (ATS) is high and significantly contributing to HIV risk. SMARTgirl Plus will add demonstrated approaches to ATS and HIV prevention (conditional cash transfer (CCT) and microfinance (MF) opportunities) into an existing widely disseminated program (SMARTgirl), using a stepped wedge randomized cluster design, and assess impacts on HIV related risk behavior. Adding CCT and MF to existing HIV prevention programs will broaden the scope of the current prevention model which focuses principally on reducing sexual risk through condom use and STI care, and uptake of reproductive health services.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
HIV
  • Behavioral: Contingency Cash Transfer
  • Behavioral: Contingency Cash Transfer
    Active amphetamine substance users will be enrolled into a 16-week Contingency Cash Transfer intervention designed to reduce use of amphetamine.
Contingency Cash Transfer
Interventions:
  • Behavioral: Contingency Cash Transfer
  • Behavioral: Contingency Cash Transfer
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1200
September 2016
September 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age or older
  • biological female
  • speaks Khmer language
  • self reports 2 or more sex partners and/or transactional sex in last month
  • able to provide informed consent

Exclusion Criteria:

  • male sex
  • under 18 years of age
  • unable to speak Khmer language
  • unable to consent
Female
18 Years and older
No
Contact: Ellen S Stein, MPH (415) 597-9299 estein@epi.ucsf.edu
Cambodia
 
NCT01835574
1R01DA033672, 5R01DA033672
Yes
University of California, San Francisco
University of California, San Francisco
National Institutes of Health (NIH)
Principal Investigator: Kimberly Page, PhD. University of California, San Franciscco
University of California, San Francisco
July 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP